Press release
Opioid Use Disorder Market Projected to Reach USD 12.8 Billion by 2034, Growing at 7.5% CAGR
Opioid Use Disorder
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70804
Key Takeaways
• Market Size (2024): USD 6.0 billion
• Forecast Size (2034): USD 12.8 billion
• CAGR (2025-2034): 7.5%
• Dominant Region: North America
• Major Drivers: Escalating opioid abuse, adoption of pharmacological and behavioral therapies, expansion of treatment centers, and government-led intervention programs.
Market Overview
Opioid Use Disorder is a chronic, relapsing condition characterized by the compulsive use of opioids despite harmful consequences. The market encompasses pharmacological treatments such as methadone, buprenorphine, naltrexone, and emerging therapies, along with behavioral interventions and counseling. Increasing awareness among healthcare providers and patients, along with expansion of outpatient treatment centers and addiction programs, is contributing to market growth.
Emerging technologies, including digital therapeutics and telemedicine for addiction management, are also reshaping treatment approaches and improving accessibility, particularly in remote or underserved areas.
Market Segmentation
By Treatment Type
• Pharmacological Therapies - Methadone, buprenorphine, naltrexone, and combination therapies.
• Behavioral Therapy & Counseling - Cognitive-behavioral therapy (CBT), contingency management, and motivational interviewing.
• Supportive Care - Telemedicine, mobile apps, and digital monitoring solutions.
By End User
• Hospitals & Clinics
• Specialty Addiction Treatment Centers
• Outpatient Programs
• Community & Public Health Programs
By Region
• North America: Largest market due to high prevalence of opioid abuse, established treatment infrastructure, and supportive regulations.
• Europe: Growing market with increasing adoption of pharmacological and behavioral treatments.
• Asia-Pacific: Emerging market supported by rising awareness and healthcare infrastructure improvements.
• Latin America & Middle East/Africa: Expanding due to rising opioid misuse and government intervention programs.
Explore Full Report here: https://exactitudeconsultancy.com/reports/70804/opioid-use-disorder-market
Market Drivers
• Increasing global prevalence of opioid misuse and addiction.
• Expansion of treatment facilities and public health intervention programs.
• Technological advancements in digital therapeutics and telemedicine solutions.
• Growing adoption of pharmacological and behavioral therapies to reduce relapse rates.
Industry Trends & Opportunities
• Introduction of long-acting injectable formulations to improve adherence.
• Growing telemedicine-based addiction management programs.
• Integration of digital monitoring and predictive analytics in treatment plans.
• Increased collaboration between pharmaceutical companies, healthcare providers, and government initiatives to expand access to therapy.
Challenges
• High treatment costs, particularly for novel pharmacological therapies.
• Regulatory and policy constraints affecting market access in some regions.
• Stigma associated with addiction limiting treatment adoption.
• Need for long-term follow-up to ensure successful recovery and reduce relapse rates.
Conclusion
The Opioid Use Disorder Market is set for significant growth over the next decade, fueled by rising prevalence, technological innovations, and expanding treatment adoption. The market presents opportunities for pharmacological, behavioral, and digital solutions that improve patient outcomes and help mitigate the global opioid crisis.
This report is also available in the following languages : Japanese (オピオイド使用障害市場), Korean (오피오이드 사용 장애 시장), Chinese (阿片类药物使用障碍市场), French (Marché des troubles liés à l'utilisation d'opioïdes), German (Markt für Opioidkonsumstörungen), and Italian (Mercato dei disturbi da uso di oppioidi), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/70804
Our More Reports:
Methylnaltrexone Bromide Market
https://exactitudeconsultancy.com/reports/66412/methylnaltrexone-bromide-market
Opioid Use Disorder Market
https://exactitudeconsultancy.com/reports/70804/opioid-use-disorder-market
Opioid Withdrawal Syndrome Market
https://exactitudeconsultancy.com/reports/70805/opioid-withdrawal-syndrome-market
Substance Use Disorder Market
https://exactitudeconsultancy.com/reports/70806/substance-use-disorder-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Opioid Use Disorder Market Projected to Reach USD 12.8 Billion by 2034, Growing at 7.5% CAGR here
News-ID: 4313118 • Views: …
More Releases from Exactitude Consultancy
Nasal Polyposis Market Growing at a CAGR of approximately 6.5%
Market Overview
The global Nasal Polyposis Market is expanding due to rising prevalence of chronic rhinosinusitis with nasal polyps (CRSwNP), increasing awareness of ENT conditions, and advancements in treatment options. In 2024, the market was valued at approximately USD 6.8 billion and is expected to reach around USD 12.1 billion by 2034, growing at a CAGR of approximately 6.5%.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/70749
Key Market Drivers
• Rising Prevalence of…
Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Market Forecast 2025-2034
Market Overview
The Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) Market continues to grow due to rising sinus-related disorders, increasing environmental pollution, and advancements in diagnostic imaging and treatment approaches. In 2024, the global market value was estimated to be over USD 9.5 billion, with expectations to reach approximately USD 16.8 billion by 2034, registering a CAGR of around 6.0%.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/70758
Key Market Drivers
• Increasing Prevalence of…
Cerebral Palsy Market Projected to Reach USD 6.1 Billion by 2034
Pune, India, December 2025 - The global Cerebral Palsy Market is expected to grow from an estimated USD 3.4 billion in 2024 to USD 6.1 billion by 2034, reflecting a CAGR of approximately 6.2% over the forecast period. Growth is driven by increasing awareness, early diagnosis, advancements in assistive technologies, and rising adoption of therapeutic interventions to improve mobility and quality of life for patients.
Download Full PDF Sample Copy of…
Sciatica Market Projected to Reach USD 4.8 Billion by 2034, Growing at 5.8% CAGR
Pune, India, December 2025 - The global Sciatica Market is expected to grow from an estimated USD 2.9 billion in 2024 to USD 4.8 billion by 2034, reflecting a CAGR of approximately 5.8% during the forecast period. The market growth is fueled by increasing incidence of lower back pain and nerve compression disorders, rising awareness of non-invasive and minimally invasive treatment options, and expanding access to advanced therapeutic devices.
Download Full…
More Releases for Opioid
Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting…
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Opioid Use Disorder (OUD) Market Size By 2025?
The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound…
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market?
The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain…
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market?
The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance…
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market?
The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the…
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana.
Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622
Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal…
